been converted into a firm contract. The assignment is with Aker BP at the Skarv field on the Norwegian Continental Shelf and covers a six-month period, with additional options. It is scheduled to ...

value chain, TGS offers a comprehensive range of insights to help clients make better decisions. Our broad range of products and advanced data technologies, coupled with a global, extensive and ...

Investment-as-a-Service solution, including its custody services. "This strengthened collaboration underscores Fair Investment's confidence in our technology and services. We are proud to support Fair ...

approved a prospectus prepared by Golar LNG Limited ("Golar") in connection with an application for listing on the Oslo Stock Exchange of the bond issued by Golar with ISIN NO0013331223.

-12 of the Norwegian Securities Trading Act. To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.

periods in the Private Placement. The Company is pleased to announce that it has now raised approximately NOK 24.2 of previously incurred debt (in total approximately NOK 16.2 million) and partly by ...

at 10:00 AM Eastern Time / 3:00 PM Oslo Time / 6:00 PM Dubai Time on March server.com/register/BIadc73dba896340318c68ac4eff4616c8) and complete the online ...

per year and is defined as a very large contract (4) for the company. «We are grateful for the trust that Equinor has placed in PSW Technology by exercising the first option of the frame agreement.

and with headquarters in Averøy, Nordmøre. The Company has a fully integrated and well-developed value chain from genetics to sales and has had a significant breakthrough in early phase production. A ...

raised NOK 1,000 million across 3 tranches with tenors of 3, 5 and 7 years. back NOK 137 million of its outstanding senior unsecured bond FKOV14 PRO due 29 December 2025 (with ISIN: NO0010915374) and ...

-shares (corresponding to a nominal value of USD 1,754.63) as a result of the exercise of a corresponding number of Restricted Share Units. All new shares are subscribed for in cash at DKK 0.08 per ...

UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD ...